{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:12:21Z","timestamp":1771013541405,"version":"3.50.1"},"reference-count":66,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T00:00:00Z","timestamp":1770940800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["IFPNC: 009-117-2020"],"award-info":[{"award-number":["IFPNC: 009-117-2020"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>Ageing-associated cancers are characterised by the dual hallmarks of persistent DNA damage and the ability of tumour cells to escape senescence checkpoints, which drive genomic instability and uncontrolled proliferation. In this study, we identified crucial proteins with PDB IDs\u20142YEX (Chk1 kinase), 4HG7 (MDM2 E3 ubiquitin ligase), 4JSX (mTOR kinase domain), and 5DS3 (PARP-1 DNA repair enzyme)\u2014involved in ageing-related cancers and performed docking studies with Extra Precision (XP) followed by MM-GBSA-based pose processing against the FDA-approved DrugBank library (LigPrep: 10907 compounds). The extensive docking computations identified many good candidates; however, Mitoxantrone emerges as the topmost candidate with docking scores of \u22126.23 to \u221216.044 Kcal\/mol and MM-GBSA score of \u221249.19 to \u221285.14 Kcal\/mol, which currently is being used to treat advanced prostate cancer and acute nonlymphocytic leukaemia (ANLL) and would be easier to repurpose to other ageing-related cancers. Mitoxantrone also emerges as a better candidate compared to the control drug Doxorubicin. Further, the complex of all 4 proteins with Mitoxantrone was taken for interaction fingerprints and found that the most interacting residues with counts were 6GLY, 6VAL, 5GLU, 5LEU, 4ALA, 3ASP, and 3TYR, among others. The pharmacokinetics and Density Functional Theory computations further support Mitoxantrone as a potential candidate. We also performed a 5-nanoseconds (ns) WaterMap for hydration site identification and the role of water in stabilisation of the complex, followed by a 100 ns MD Simulation that resulted in stable deviation and fluctuations mostly under &lt;2\u00c5 and a web of simulation interactions making the complex stable. Furthermore, the same trajectories were used for the Binding Free and Total Complex Energies computations, revealing that the complexes were stable. All the studies, from protein energies to docking to simulation and binding free energy, supported the stable complexes; however, experimental studies are necessary before their use.<\/jats:p>","DOI":"10.1371\/journal.pone.0341446","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:37:41Z","timestamp":1771007861000},"page":"e0341446","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-8237-9079","authenticated-orcid":true,"given":"Mohammed H.","family":"Al-Qahtani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mourad","family":"Assidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelbaset","family":"Buhmeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Almuhammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Natesan","family":"Pushparaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nofe Ateq","family":"Alganmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,2,13]]},"reference":[{"issue":"1","key":"pone.0341446.ref001","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-024-02020-z","article-title":"Aging and cancer","volume":"23","author":"L Mont\u00e9gut","year":"2024","journal-title":"Mol Cancer"},{"issue":"2","key":"pone.0341446.ref002","doi-asserted-by":"crossref","first-page":"118","DOI":"10.4103\/AGINGADV.AGINGADV-D-24-00023","article-title":"Common features between aging and cancer: a narrative review","volume":"1","author":"M Abubakar","year":"2024","journal-title":"Aging Advances"},{"issue":"6","key":"pone.0341446.ref003","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1080\/1061186X.2024.2347358","article-title":"An extensive review on lung cancer therapeutics using machine learning techniques: state-of-the-art and perspectives","volume":"32","author":"S Ahmad","year":"2024","journal-title":"J Drug Target"},{"issue":"10","key":"pone.0341446.ref004","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1080\/1061186X.2025.2530656","article-title":"Machine learning for genomic profiling and drug discovery in personalised lung cancer therapeutics","volume":"33","author":"S Ahmad","year":"2025","journal-title":"J Drug Target"},{"issue":"9","key":"pone.0341446.ref005","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1097\/JS9.0000000000002752","article-title":"Global, regional, and national burden of primary liver cancer among middle-aged and elderly populations from 2000 to 2021 with a prediction to 2050: a cross-sectional analysis from Global Burden of Disease Study 2021","volume":"111","author":"B Wang","year":"2025","journal-title":"Int J Surg"},{"issue":"1","key":"pone.0341446.ref006","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"RL Siegel","year":"2025","journal-title":"Ca"},{"issue":"2","key":"pone.0341446.ref007","doi-asserted-by":"crossref","DOI":"10.1002\/bjs.10053","article-title":"Molecular and biological hallmarks of ageing","volume":"103","author":"JR Aunan","year":"2016","journal-title":"Br J Surg"},{"issue":"11","key":"pone.0341446.ref008","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.3390\/antiox11112228","article-title":"Ageing and Low-Level Chronic Inflammation: The Role of the Biological Clock","volume":"11","author":"B Colombini","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"pone.0341446.ref009","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.cellsig.2011.12.006","article-title":"Emerging role of NF-\u03baB signaling in the induction of senescence-associated secretory phenotype (SASP)","volume":"24","author":"A Salminen","year":"2012","journal-title":"Cell Signal"},{"key":"pone.0341446.ref010","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2147\/JIR.S442106","article-title":"Revolutionizing Treatment Strategies for Autoimmune and Inflammatory Disorders: The Impact of Dipeptidyl-Peptidase 4 Inhibitors","volume":"17","author":"K Rahim","year":"2024","journal-title":"J Inflamm Res"},{"issue":"1","key":"pone.0341446.ref011","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<100::AID-PATH236>3.0.CO;2-T","article-title":"Cellular senescence and cancer","volume":"187","author":"D Wynford-Thomas","year":"1999","journal-title":"J Pathol"},{"issue":"23","key":"pone.0341446.ref012","doi-asserted-by":"crossref","first-page":"14672","DOI":"10.3390\/ijms232314672","article-title":"DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities","volume":"23","author":"D Jurkovicova","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"5","key":"pone.0341446.ref013","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1136\/gutjnl-2016-312623","article-title":"CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells","volume":"67","author":"G Manic","year":"2018","journal-title":"Gut"},{"issue":"4","key":"pone.0341446.ref014","doi-asserted-by":"crossref","first-page":"805","DOI":"10.20892\/j.issn.2095-3941.2020.0177","article-title":"Evolving insights: how DNA repair pathways impact cancer evolution","volume":"17","author":"J Zhou","year":"2020","journal-title":"Cancer Biol Med"},{"key":"pone.0341446.ref015","doi-asserted-by":"crossref","first-page":"133872","DOI":"10.1016\/j.ijbiomac.2024.133872","article-title":"Reporting multitargeted potency of Tiaprofenic acid against lung cancer: Molecular fingerprinting, MD simulation, and MTT-based cell viability assay studies","volume":"276","author":"S Ahmad","year":"2024","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"pone.0341446.ref016","doi-asserted-by":"crossref","DOI":"10.1177\/1934578X221115499","article-title":"Multitargeted Molecular Dynamic Understanding of Butoxypheser Against SARS-CoV-2: An in Silico Study","volume":"17","author":"S Ahmad","year":"2022","journal-title":"Natural Product Communications"},{"issue":"6","key":"pone.0341446.ref017","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.bmcl.2012.01.043","article-title":"Synthesis and evaluation of triazolones as checkpoint kinase 1 inhibitors","volume":"22","author":"V Oza","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"pone.0341446.ref018","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1107\/S0907444913004459","article-title":"The structure of an MDM2-Nutlin-3a complex solved by the use of a validated MDM2 surface-entropy reduction mutant","volume":"69","author":"B Anil","year":"2013","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"7448","key":"pone.0341446.ref019","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12122","article-title":"mTOR kinase structure, mechanism and regulation","volume":"497","author":"H Yang","year":"2013","journal-title":"Nature"},{"issue":"5","key":"pone.0341446.ref020","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molcel.2015.10.013","article-title":"PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain","volume":"60","author":"JM Dawicki-McKenna","year":"2015","journal-title":"Mol Cell"},{"issue":"11","key":"pone.0341446.ref021","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.3390\/cells8111446","article-title":"Dissecting Aging and Senescence-Current Concepts and Open Lessons","volume":"8","author":"C Schmeer","year":"2019","journal-title":"Cells"},{"issue":"12","key":"pone.0341446.ref022","first-page":"485","article-title":"The Senescence-Associated Secretory Phenotype (SASP) in the Challenging Future of Cancer Therapy and Age-Related Diseases","volume":"9","author":"L Cuollo","year":"2020","journal-title":"Biology (Basel)"},{"issue":"1","key":"pone.0341446.ref023","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12943-024-02096-7","article-title":"Cellular senescence and SASP in tumor progression and therapeutic opportunities","volume":"23","author":"Z Dong","year":"2024","journal-title":"Mol Cancer"},{"issue":"16","key":"pone.0341446.ref024","doi-asserted-by":"crossref","first-page":"8037","DOI":"10.3390\/ijms26168037","article-title":"Redefining Chemoresistance: Natural Bioactives as Molecular Modulators at the Cancer-Tumor Microenvironment Interface","volume":"26","author":"C Reytor-Gonz\u00e1lez","year":"2025","journal-title":"Int J Mol Sci"},{"key":"pone.0341446.ref025","doi-asserted-by":"crossref","first-page":"146175","DOI":"10.1016\/j.ijbiomac.2025.146175","article-title":"Evaluating the polypharmacological potential of cosmetic preservative Imidurea against Lung Cancer-associated EGFR, CDK2, STAT3, BCL2, p53, and ABCB1 proteins","volume":"321","author":"S Ahmad","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"pone.0341446.ref026","doi-asserted-by":"crossref","first-page":"16545","DOI":"10.1038\/s41598-023-43789-1","article-title":"In-silico and in-vitro study reveals ziprasidone as a potential aromatase inhibitor against breast carcinoma","volume":"13","author":"A Sahu","year":"2023","journal-title":"Sci Rep"},{"issue":"11","key":"pone.0341446.ref027","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12032-023-02203-6","article-title":"Multitargeted inhibitory effect of Mitoxantrone 2HCl on cervical cancer cell cycle regulatory proteins: a multitargeted docking-based MM\\GBSA and MD simulation study","volume":"40","author":"MA Alshehri","year":"2023","journal-title":"Med Oncol"},{"issue":"9","key":"pone.0341446.ref028","doi-asserted-by":"crossref","first-page":"868","DOI":"10.2174\/1389200218666170728115606","article-title":"Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer\u2019s and Parkinson\u2019s Diseases","volume":"18","author":"Q Alam","year":"2017","journal-title":"Curr Drug Metab"},{"key":"pone.0341446.ref029","first-page":"191","volume-title":"Deep learning in computer-aided drug design: a case study. Deep learning applications in translational bioinformatics","author":"S Ahmad","year":"2024"},{"key":"pone.0341446.ref030","doi-asserted-by":"crossref","first-page":"142343","DOI":"10.1016\/j.ijbiomac.2025.142343","article-title":"Probing the multitargeted potency of Theodrenaline and its comparative evaluation with Crizotinib against transferase, hydrolase, signalling, and apoptosis-related proteins to overcome lung cancer drug resistance","volume":"308","author":"S Ahmad","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"16","key":"pone.0341446.ref031","doi-asserted-by":"crossref","first-page":"8268","DOI":"10.1080\/07391102.2023.2248260","article-title":"Unveiling the multitargeted potency of Sodium Danshensu against cervical cancer: a multitargeted docking-based, structural fingerprinting and molecular dynamics simulation study","volume":"42","author":"S Alghamdi","year":"2024","journal-title":"J Biomol Struct Dyn"},{"key":"pone.0341446.ref032","doi-asserted-by":"crossref","first-page":"141703","DOI":"10.1016\/j.ijbiomac.2025.141703","article-title":"Evaluating the polypharmacological potency of FEDPN from ChEMBL BioAssays against lung cancer EGFR, ALK, TrkA and KRAS proteins","volume":"306","author":"S Ahmad","year":"2025","journal-title":"Int J Biol Macromol"},{"issue":"10","key":"pone.0341446.ref033","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nrd1523","article-title":"The role of the medicinal chemist in drug discovery--then and now","volume":"3","author":"JG Lombardino","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"pone.0341446.ref034","doi-asserted-by":"crossref","first-page":"1611972","DOI":"10.3389\/fchem.2025.1611972","article-title":"Integrative computational approaches identify haptoglobin inhibitors to modulate erythrocyte sedimentation rate in trauma-linked inflammatory and haematological malignancies","volume":"13","author":"AH Al Khzem","year":"2025","journal-title":"Front Chem"},{"issue":"1","key":"pone.0341446.ref035","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/17460441.2023.2267015","article-title":"The application of WaterMap-guided structure-based virtual screening in novel drug discovery","volume":"19","author":"AA Kaczor","year":"2024","journal-title":"Expert Opin Drug Discov"},{"issue":"23","key":"pone.0341446.ref036","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.2174\/1568026617666170414141452","article-title":"Calculating Water Thermodynamics in the Binding Site of Proteins - Applications of WaterMap to Drug Discovery","volume":"17","author":"D Cappel","year":"2017","journal-title":"Curr Top Med Chem"},{"key":"pone.0341446.ref037","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1741-7007-9-71","article-title":"Molecular dynamics simulations and drug discovery","volume":"9","author":"JD Durrant","year":"2011","journal-title":"BMC Biol"},{"issue":"3","key":"pone.0341446.ref038","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1007\/s11030-023-10648-0","article-title":"Identification of 5-nitroindazole as a multitargeted inhibitor for CDK and transferase kinase in lung cancer: a multisampling algorithm-based structural study","volume":"28","author":"S Ahmad","year":"2024","journal-title":"Mol Divers"},{"issue":"5","key":"pone.0341446.ref039","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1080\/07391102.2023.2209673","article-title":"Multisampling-based docking reveals Imidazolidinyl urea as a multitargeted inhibitor for lung cancer: an optimisation followed multi-simulation and in-vitro study","volume":"42","author":"S Ahmad","year":"2024","journal-title":"J Biomol Struct Dyn"},{"issue":"11","key":"pone.0341446.ref040","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1080\/17460441.2021.1942836","article-title":"What is the current value of MM\/PBSA and MM\/GBSA methods in drug discovery?","volume":"16","author":"T Tuccinardi","year":"2021","journal-title":"Expert Opin Drug Discov"},{"key":"pone.0341446.ref041","doi-asserted-by":"crossref","first-page":"7","DOI":"10.53388\/MDM202508008","article-title":"RCSB Protein Data Bank: revolutionising drug discovery and design for over five decades","volume":"8","author":"S Ahmad","year":"2025","journal-title":"Med Data Min"},{"key":"pone.0341446.ref042","volume-title":"Schr\u00f6dinger Suite 2025 Protein Preparation Wizard","author":"S Release","year":"2025"},{"issue":"2","key":"pone.0341446.ref043","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/prot.10613","article-title":"A hierarchical approach to all-atom protein loop prediction","volume":"55","author":"MP Jacobson","year":"2004","journal-title":"Proteins"},{"issue":"6","key":"pone.0341446.ref044","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1021\/ja00214a001","article-title":"The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin","volume":"110","author":"WL Jorgensen","year":"1988","journal-title":"J Am Chem Soc"},{"key":"pone.0341446.ref045","volume-title":"QikProp S. Schr\u00f6dinger","year":"2024"},{"issue":"12","key":"pone.0341446.ref046","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules","volume":"21","author":"JC Shelley","year":"2007","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"pone.0341446.ref047","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1021\/ct100578z","article-title":"PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pKa Predictions","volume":"7","author":"MHM Olsson","year":"2011","journal-title":"J Chem Theory Comput"},{"issue":"22","key":"pone.0341446.ref048","doi-asserted-by":"crossref","first-page":"12441","DOI":"10.3390\/ijms252212441","article-title":"Drug Repurposing for Cancer Treatment: A Comprehensive Review","volume":"25","author":"AH Al Khzem","year":"2024","journal-title":"Int J Mol Sci"},{"key":"pone.0341446.ref049","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad976","article-title":"DrugBank 6.0: the DrugBank Knowledgebase for 2024","volume":"52","author":"C Knox","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"pone.0341446.ref050","volume-title":"LigPrep","author":"S Release","year":"2025"},{"key":"pone.0341446.ref051","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.compbiolchem.2018.02.008","article-title":"Multiple grid arrangement improves ligand docking with unknown binding sites: Application to the inverse docking problem","volume":"73","author":"T Ban","year":"2018","journal-title":"Comput Biol Chem"},{"key":"pone.0341446.ref052","volume-title":"Receptor grid generation","author":"S Release","year":"2025"},{"issue":"4","key":"pone.0341446.ref053","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead- and drug-like compounds: the rule-of-five revolution","volume":"1","author":"CA Lipinski","year":"2004","journal-title":"Drug Discov Today Technol"},{"key":"pone.0341446.ref054","volume-title":"Glide: Schr\u00f6dinger","author":"S Release","year":"2024"},{"key":"pone.0341446.ref055","author":"S Maestro","year":"2025"},{"issue":"18","key":"pone.0341446.ref056","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/qua.24481","article-title":"Jaguar: A high\u2010performance quantum chemistry software program with strengths in life and materials sciences","volume":"113","author":"AD Bochevarov","year":"2013","journal-title":"Int J of Quantum Chemistry"},{"key":"pone.0341446.ref057","volume-title":"Release S. Jaguar","author":"S Release","year":"2024"},{"issue":"5","key":"pone.0341446.ref058","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1021\/acs.jctc.7b00176","article-title":"Assessing DFT-D3 Damping Functions Across Widely Used Density Functionals: Can We Do Better?","volume":"13","author":"J Witte","year":"2017","journal-title":"J Chem Theory Comput"},{"key":"pone.0341446.ref059","volume-title":"A general SCF theory","author":"R Carb\u00f3","year":"2012"},{"issue":"3","key":"pone.0341446.ref060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1080\/00387010.2024.2432331","article-title":"Vibrational spectroscopic characterization, quantum chemical, molecular docking and molecular dynamics investigations of cyclo(L-phenylalanyl-L-proline), an anticancer agent","volume":"58","author":"TS Oktemer","year":"2024","journal-title":"Spectroscopy Letters"},{"issue":"10","key":"pone.0341446.ref061","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1063\/1.449880","article-title":"Direct inversion in the iterative subspace (DIIS) optimization of open-shell, excited-state, and small multiconfiguration SCF wave functions","volume":"84","author":"TP Hamilton","year":"1986","journal-title":"The Journal of Chemical Physics"},{"issue":"8","key":"pone.0341446.ref062","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1134\/S0036024425701249","article-title":"The Significance of Doxylamine, an Antihistamine Compound, in the Context of Its Potential Efficacy against COVID-19: Conformational Analysis, Molecular Docking, and Molecular Dynamics Studies","volume":"99","author":"Er Alev","year":"2025","journal-title":"Russ J Phys Chem"},{"key":"pone.0341446.ref063","volume-title":"Release S. Desmond molecular dynamics system","author":"S Desmond","year":"2024"},{"issue":"43","key":"pone.0341446.ref064","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K","volume":"105","author":"P Mark","year":"2001","journal-title":"J Phys Chem A"},{"issue":"1","key":"pone.0341446.ref065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/00268977200100031","article-title":"NpT-ensemble Monte Carlo calculations for binary liquid mixtures","volume":"23","author":"IR McDonald","year":"1972","journal-title":"Molecular Physics"},{"issue":"16","key":"pone.0341446.ref066","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-Point Binding Free Energy Calculation with MM\/PBSA and MM\/GBSA: Strategies and Applications in Drug Design","volume":"119","author":"E Wang","year":"2019","journal-title":"Chem Rev"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:37:52Z","timestamp":1771007872000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0341446"}},"subtitle":[],"editor":[{"given":"Chandrabose","family":"Selvaraj","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,2,13]]},"references-count":66,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0341446","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,13]]}}}